ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Autophagy is induced in both CML cell lines and Leukemic Stem Cells (LSCs) following in vitro treatment with imatinib, suggesting that BCR-ABL acts as a negative regulator of autophagy (110).